Protecting a Woman’s Skeleton
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Osteoporosis, the most common bone disease, is a silent condition resulting in increased fracture risk. Preventive methods for adulthood, early recognition of osteoporosis followed by timely and effective management can reduce fracture risk. Several pharmacologic therapies are currently available, and when choosing from the available options, clinicians should consider the efficacy and safety profiles of each therapy as well as the individual patient’s needs and overall health. Ideally, therapy should satisfy multiple criteria: fracture protection across multiple skeletal sites; rapid onset of action to maximize the timing of fracture protection; and minimal side effects with proven long-term safety.
Abstract
Osteoporosis, the most common bone disease, is a silent condition resulting in increased fracture risk. Preventive methods for adulthood, early recognition of osteoporosis followed by timely and effective management can reduce fracture risk. Several pharmacologic therapies are currently available, and when choosing from the available options, clinicians should consider the efficacy and safety profiles of each therapy as well as the individual patient’s needs and overall health. Ideally, therapy should satisfy multiple criteria: fracture protection across multiple skeletal sites; rapid onset of action to maximize the timing of fracture protection; and minimal side effects with proven long-term safety.
참고문헌 (11)
- Lim LS, "Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice", Am J Prev Med, 36, pp.366~375 (2009)
- Riggs BL, "Involutional osteoporosis", N Engl J Med, 314, pp.1676~1686 (1986)
- Bjarnason NH, "Number of years since menopause: spontaneous bone loss is dependent but response to hormone replacement therapy is independent", Bone, 30, pp.637~642 (2002)
- Arabi A, "Bone mineral density by age, gender, pubertal stages, and socioeconomic status in healthy Lebanese children and adolescents", Bone, 35, pp.1169~1179 (2004)
- Bonjour JP, "The importance and relevance of peak bone mass in the prevalence of osteoporosis", Salud Publica Mex, 51(Suppl 1), pp.5~17 (2009)
- Looker AC, "Updated data on proximal femur bone mineral levels of US adults", Osteoporos Int, 8, pp.468~489 (1998)
- Verhaar HJ, "Medical treatment of osteoporosis in the elderly", Aging Clin Exp Res, 21, pp.407~413 (2009)
- Howard E, "FPIN's clinical inquiries. Combination therapy for postmenopausal osteoporosis", Am Fam Physician, 81, pp.439~ (2010)
- "What to do about postmenopausal fracture risk. Diet, exercise, calcium, and vitamin D are always important, but women at high risk for fractures may need drug therapy, too", Harv Womens Health Watch, 17, pp.1~3 (2009)
- Bischoff-Ferrari HA, "Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials", Jama, 293, pp.2257~2264 (2005)
- Stefanick ML, "Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration", Am J Med, 118(Suppl 12B), pp.64~73 (2005)